logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Emerging Concepts Targeting Immune Checkpoints In Cancer And Autoimmunity 1st Edition Akihiko Yoshimura Eds

  • SKU: BELL-6842068
Emerging Concepts Targeting Immune Checkpoints In Cancer And Autoimmunity 1st Edition Akihiko Yoshimura Eds
$ 31.00 $ 45.00 (-31%)

4.1

40 reviews

Emerging Concepts Targeting Immune Checkpoints In Cancer And Autoimmunity 1st Edition Akihiko Yoshimura Eds instant download after payment.

Publisher: Springer International Publishing
File Extension: PDF
File size: 5.25 MB
Pages: 268
Author: Akihiko Yoshimura (eds.)
ISBN: 9783319689289, 9783319689296, 3319689282, 3319689290
Language: English
Year: 2017
Edition: 1

Product desciption

Emerging Concepts Targeting Immune Checkpoints In Cancer And Autoimmunity 1st Edition Akihiko Yoshimura Eds by Akihiko Yoshimura (eds.) 9783319689289, 9783319689296, 3319689282, 3319689290 instant download after payment.

This volume reviews the current state of research on immune checkpoints and offers novel concepts. It discusses the two most important immune checkpoints: T lymphocyte-associated antigen-4 (CTLA-4) and programmed cell death-1 (PD-1). It shows that antagonistic antibodies against these two molecules are highly effective in the treatment of various cancers and that PD-1 and CTLA-4 have been linked to the suppression of T-cell receptor signaling and co-stimulatory molecules. Further, the volume examines other agents, a number of cells, receptors and signaling molecules, that are also involved in the regulation of T-cell activation and extends the concept of immune checkpoints to “molecules and cells that negatively regulate T-cell activation”. Playing essential roles in immune homeostasis, they could offer new targets for cancer immunotherapy, and for the therapy of autoimmune diseases.

Written by internationally respected scientists, this book will appeal to basic scientists, clinicians, drug development researchers, and advanced students alike.

Related Products